SCHEMBL6345888

SCHEMBL6345888

CCN1C(=O)c2cccc3c(S(=O)(=O)N(C)C)ccc(c23)C1=O

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 11/20 0.64
▸ PKM P14618 2/20 0.62
▸ CYP1B1 Q16678 3/20 0.58
▸ ALDH1A1 P00352 3/20 0.58
▸ MEN1 O00255 3/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ ATM Q13315 2/20 0.58
▸ LMNA P02545 2/20 0.58
▸ USP2 O75604 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ KEAP1 Q14145 1/20 0.58
▸ NFE2L2 Q16236 1/20 0.58
▸ CLTC Q00610 1/20 0.53
▸ MAPT P10636 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ PLK1 P53350 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ CASP1 P29466 1/20 0.48
▸ CASP7 P55210 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9006326 0.83 CYP1B1 (0.61) BRD4PKMCYP1B1ALDH1A1MEN1
SCHEMBL3853105 0.81 MEN1 (0.57) BRD4PKMALDH1A1MEN1KMT2A
SCHEMBL17407730 0.75 CYP1B1 (0.69) BRD4CYP1B1ALDH1A1MEN1KMT2A
SCHEMBL9148660 0.75 BRD4 (0.50) BRD4PKMCYP1B1ALDH1A1MEN1
SCHEMBL19033208 0.74 CYP1B1 (0.64) BRD4CYP1B1ALDH1A1MEN1KMT2A
SCHEMBL11213051 0.74 BRD4 (0.65) BRD4PKMALDH1A1MEN1KMT2A
SCHEMBL9450615 0.74 BRD4 (0.73) BRD4PKMALDH1A1MEN1KMT2A
SCHEMBL2530062 0.74 CYP1B1 (1.00) CYP1B1ALDH1A1MEN1KMT2AATM
SCHEMBL31373095 0.74 CYP1B1 (1.00) CYP1B1ALDH1A1MEN1KMT2AATM
SCHEMBL6347785 0.74 ALDH1A1 (1.00) BRD4CYP1B1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173226-B2 Polymerizable compound , polyethylene glycol mono(meth)acrylate, a polystyrene oligomer having a methacryloyl group at one terminal, acrylic macromonomer imides FUJIFILM CORPORATION (JP) 2012-05-08 — — US disclosed
US-20090214797-A1 INKJET INK COMPOSITION, AND INKJET RECORDING METHOD AND PRINTED MATERIAL EMPLOYING SAME FUJIFILM CORPORATION (JP) 2009-08-27 — — US disclosed
US-20090214797-A1 INKJET INK COMPOSITION, AND INKJET RECORDING METHOD AND PRINTED MATERIAL EMPLOYING SAME FUJIFILM CORPORATION (JP) 2009-08-27 — — US disclosed
US-20080241416-A1 POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD FUJIFILM CORPORATION (JP) 2008-10-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241416-A1 POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD CNOT1, CCNT1, SCO2 BRD4 717/4885PKM 1190/4885CYP1B1 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback